Olympia Pharmaceuticals Expands into Alabama with New Licensing, Bringing GLP-1s and More to Healthcare Providers ORLANDO, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Olympia Pharmaceuticals, a state-of-the-art, FDA-registered 503B pharmaceutical outsourcing facility, is proud to announce its expansion into...

Olympia Pharmaceuticals Purchases 55,000 Sq Ft Facility in Florida ORLANDO, Fla., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Olympia Pharmaceuticals, a state-of-the-art, FDA 503B pharmaceutical outsourcing facility and 503A pharmacy, today announced it has purchased a...

Olympia Pharmaceuticals Bolsters Leadership Team with New Executive Appointments ORLANDO, Fla., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Olympia Pharmaceuticals, a state-of-the-art, FDA 503B pharmaceutical outsourcing facility and 503A pharmacy, announces today the appointment of...